Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2014-10-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of our study is to compare gait parameters (gait speed and energy cost) with a classical 4-point canne and with 4-roll canne.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane
NCT05163444
Gait Rehabilitation Post Stroke:the Long Term Effect of Two Walking Aids -Canes and TheraTogs
NCT01366729
Effects of a Provision of a Cane After Stroke
NCT03150979
Gait Perturbations to Improve Balance Post-stroke
NCT04314830
The Influence of Cortical Lateralization on Selective Motor Control of the Arm Swing During Independent Walking After Stroke.
NCT06442579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OBJECTIVE To compare the gait parameters with a 4-point canne and with a 4-roll canne METHODS The investigators will recruited stroke patients who necessitate 4 point-canne as walking aids. A 10 meters walking test, a 6 minutes walking test, an estimated energy cost and a patient's satisfaction will be monitored with a 4-point canne (day 1) and with a 4-roll canne (day 2) in a cross-over study. The first tested device will be randomized.
PERSPECTIVE The investigators hope to demonstrate that a 4-roll canne makes possible to walk faster in a safe way after stroke
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4-point canne
Stroke patients walk with 4-point canne
4-roll canne
4-roll canne
Stroke patients walk with 4-roll canne
4-roll canne
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4-roll canne
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to walk 10 meters
Exclusion Criteria
* need support when walking
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Mont-Godinne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deltombe Thierry
Professeur Clinique
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry Deltombe, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Dinant Godinne / UcL Namur
Geoffroy Dellicour, PT
Role: PRINCIPAL_INVESTIGATOR
Centre Neurologique William Lennox Ottignies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deltombe Thierry
Yvoir, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MG-4roll-53/2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.